Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTED.L Regulatory News (TED)

  • There is currently no data for TED

Litigation Update

31 Oct 2014 07:00

RNS Number : 7378V
Ted Baker PLC
31 October 2014
 

 

31 October 2014

 

 

Ted Baker PLC ('Ted Baker' or the 'Group')

 

 

Litigation Update

 

 

Ted Baker has received judgment from the High Court that its on-going claim against AXA Insurance UK PLC, its previous insurers, for loss of profit arising from the theft of inventory from its warehouse from 2004 to 2008 has not been upheld.

 

A further hearing to determine the award of costs is expected to be held in the next few weeks.

 

Ted Baker is disappointed with this outcome and is considering its options. This judgment will have no significant impact on the financial position of the Group and no impact on its trading.

 

As disclosed in the Interim Results announcement for the 28 weeks ended 9 August 2014, Ted Baker has provided £2.6 million for its own legal costs incurred up to 9 August 2014 and those results did not include any contingent asset for the claim. In line with the Group's accounting treatment, any additional costs that may arise from this judgment will be treated as an exceptional item.

 

A further announcement will be made as appropriate.

 

 

 

 

Enquiries:

 

Ted Baker Tel: 020 7255 4800

Lindsay Page

Chief Operating Officer & Group Finance Director

 

Hudson Sandler Tel: 020 7796 4133

Alex Brennan / Michael Sandler

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMBITMBMJBII
Date   Source Headline
18th May 202210:08 amRNSForm 8.3 -Ted Baker PLC
17th May 20223:05 pmRNSRule 2.9 Announcement
17th May 202212:23 pmRNSForm 8.3 - Ted Baker plc
17th May 20229:58 amRNSForm 8.3 - Ted Baker PLC
17th May 20229:45 amRNSForm 8.5 (EPT/RI)
17th May 20228:46 amRNSForm 8.5 (EPT/RI)
16th May 20222:10 pmRNSForm 8.3 - Ted Baker plc
16th May 202210:56 amRNSForm 8.3 - Ted Baker PLC
16th May 202210:34 amRNSForm 8.5 (EPT/RI)
16th May 20229:12 amRNSForm 8.5 (EPT/RI)
13th May 20222:45 pmRNSForm 8.3 - Ted Baker Plc
13th May 20221:55 pmRNSForm 8.3 - Ted Baker plc
13th May 202210:48 amRNSForm 8.5 (EPT/RI)
12th May 20223:25 pmRNSForm 8.3 - Ted Baker Plc
12th May 20223:20 pmRNSForm 8.3 - Ted Baker plc
12th May 20222:38 pmRNSForm 8.3 - Ted Baker plc
12th May 202210:54 amRNSForm 8.5 (EPT/RI)
11th May 20222:16 pmRNSForm 8.3 - Ted Baker PLC
11th May 20221:28 pmRNSForm 8.3 - Ted Baker plc
11th May 202212:30 pmRNSForm 8.5 (EPT/RI)
10th May 20221:54 pmRNSForm 8.3 - Ted Baker plc
10th May 202212:27 pmGNWForm 8.3 - Ted Baker
10th May 202210:12 amRNSForm 8.5 (EPT/RI)
10th May 20229:33 amRNSForm 8.3 - Ted Baker PLC
10th May 20229:04 amRNSForm 8.5 (EPT/RI)
10th May 20227:22 amRNSForm 8.3 - TED BAKER PLC
9th May 20223:16 pmRNSForm 8.3 - Ted Baker plc
9th May 202212:46 pmRNSForm 8.3 - Ted Baker plc
9th May 20229:56 amRNSForm 8.3 - Ted Baker PLC
9th May 20227:00 amRNSForm 8.3 - TED BAKER PLC
6th May 20223:20 pmRNSForm 8.3 - Ted Baker plc
6th May 202212:25 pmRNSForm 8.3 - Ted Baker plc
6th May 202210:55 amRNSForm 8.5 (EPT/RI)
6th May 202210:06 amRNSForm 8.3 - Ted Baker PLC
6th May 20228:46 amRNSForm 8.5 (EPT/RI)
5th May 20221:19 pmRNSForm 8.3 - Ted Baker plc
5th May 202210:49 amRNSForm 8.5 (EPT/RI)
5th May 20229:57 amRNSForm 8.3 - Ted Baker PLC
5th May 20229:29 amRNSTotal Voting Rights
5th May 20228:40 amRNSForm 8.5 (EPT/RI)
4th May 20221:43 pmRNSForm 8.3 - Ted Baker plc
4th May 202210:24 amRNSForm 8.3 - Ted Baker PLC
4th May 20229:56 amRNSForm 8.5 (EPT/RI)
3rd May 20223:00 pmRNSBlock listing Interim Review
3rd May 202211:55 amRNSForm 8.3 - Ted Baker plc
3rd May 20229:14 amRNSForm 8.5 (EPT/RI)
29th Apr 20221:15 pmRNSForm 8.3 - Ted Baker plc
29th Apr 20229:43 amRNSForm 8.5 (EPT/RI)
29th Apr 20228:37 amRNSForm 8.5 (EPT/RI) - Ted Baker PLC
28th Apr 202212:29 pmRNSForm 8.3 - Ted Baker plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.